WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

WMT

89.87

+1.27%↑

COST

966.28

+1.27%↑

TGT

105.83

+1.54%↑

KR

67.29

-1.25%↓

GIS

59.21

-0.8%↓

Search

Hims & Hers Health Inc

Fermé

SecteurConsommation de base

31.15 0.48

Résumé

Variation du prix de l'action

24h

Actuel

Min

28.94

Max

31.21

Chiffres clés

By Trading Economics

Revenu

-50M

26M

Ventes

80M

481M

P/E

Moyenne du Secteur

54.722

44.466

BPA

0.227

Marge bénéficiaire

5.409

Employés

1,637

EBITDA

-8.2M

19M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+55.4% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-4.7B

6.5B

Ouverture précédente

30.67

Clôture précédente

31.15

Sentiment de l'Actualité

By Acuity

18%

82%

9 / 152 Classement par Consumer defensive

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Hims & Hers Health Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

1 avr. 2025, 23:15 UTC

Principaux Mouvements du Marché

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 févr. 2025, 15:33 UTC

Principaux Mouvements du Marché

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

18 nov. 2024, 19:07 UTC

Principaux Mouvements du Marché

Hims & Hers Stock Climbs After Former Regulator Autor Joins Board

14 oct. 2024, 15:02 UTC

Principaux Mouvements du Marché

Hims & Hers Health Shares Jump After FDA Set to Reconsider Limits on Knockoff Weight-Loss Drugs

3 oct. 2024, 11:28 UTC

Principaux Mouvements du Marché

Hims & Hers Health Shares Fall After FDA Removes Eli Lilly Obesity Drugs From Shortage List

2 avr. 2025, 16:53 UTC

Actualités

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 mars 2025, 15:54 UTC

Actualités

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 févr. 2025, 23:20 UTC

Résultats

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

10 févr. 2025, 12:00 UTC

Actualités

Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business -- Heard on the Street -- WSJ

19 déc. 2024, 17:16 UTC

Actualités

FDA Says Shortage of Eli Lilly's Zepbound is Over, But Gives Compounders a Grace Period -- Barrons.com

19 déc. 2024, 15:14 UTC

Actualités

Eli Lilly's Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

19 déc. 2024, 15:02 UTC

Actualités

The Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

16 déc. 2024, 13:47 UTC

Actualités

The Weight-Loss Drug Market Is Heading for a Reckoning This Week -- Barrons.com

16 déc. 2024, 07:00 UTC

Actualités

The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect. -- Barrons.com

3 oct. 2024, 14:45 UTC

Actualités

Eli Lilly's Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 13:12 UTC

Actualités

Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 11:45 UTC

Actualités

Update: Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 10:14 UTC

Actualités

Update: Eli Lilly's Weight-Loss Drugs No Longer In Shortage. It's Bad News for These Stocks. -- Barrons.com

2 août 2024, 17:52 UTC

Acquisitions, Fusions, Rachats

Hims & Hers Plan to Sell Knockoff Weight Loss Drug Looking Shaky -- Barrons.com

26 juin 2024, 11:00 UTC

Actualités
Acquisitions, Fusions, Rachats

The War Over Cheaper Ozempic Won't End Well for Some Investors -- Heard on the Street -- WSJ

24 mai 2024, 20:37 UTC

Résultats

The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week -- WSJ

Comparaison

Variation de prix

Hims & Hers Health Inc prévision

Objectif de Prix

By TipRanks

55.4% hausse

Prévisions sur 12 Mois

Moyen 45.92 USD  55.4%

Haut 85 USD

Bas 21 USD

Basé sur 13 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

13 ratings

5

Achat

6

Maintien

2

Vente

Score Technique

By Trading Central

27.22 / 31.88Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

9 / 152Classement par Consommation de base

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.